BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15328143)

  • 1. The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli.
    Chollet R; Chevalier J; Bryskier A; Pagès JM
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3621-4. PubMed ID: 15328143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boosting the Antibacterial Activity of Azithromycin on Multidrug-Resistant
    Al-Marzooq F; Ghazawi A; Daoud L; Tariq S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes.
    Pradel E; Pagès JM
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2640-3. PubMed ID: 12121946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations.
    Mamelli L; Prouzet-Mauléon V; Pagès JM; Mégraud F; Bolla JM
    J Antimicrob Chemother; 2005 Sep; 56(3):491-7. PubMed ID: 16055509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of AdeABC and AdeIJK efflux systems of Acinetobacter baumannii compared with those of the AcrAB-TolC system of Escherichia coli.
    Sugawara E; Nikaido H
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7250-7. PubMed ID: 25246403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates.
    Ghisalberti D; Mahamoud A; Chevalier J; Baitiche M; Martino M; Pagès JM; Barbe J
    Int J Antimicrob Agents; 2006 Jun; 27(6):565-9. PubMed ID: 16707249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance phenotypes conferred by macrolide phosphotransferases.
    Chesneau O; Tsvetkova K; Courvalin P
    FEMS Microbiol Lett; 2007 Apr; 269(2):317-22. PubMed ID: 17302923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.
    Bogdanovich T; Bozdogan B; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Mar; 50(3):893-8. PubMed ID: 16495248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli.
    Cagliero C; Mouline C; Payot S; Cloeckaert A
    J Antimicrob Chemother; 2005 Nov; 56(5):948-50. PubMed ID: 16157618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of VceC gain-of-function mutants that can function with the AcrAB multiple-drug-resistant efflux pump of Escherichia coli.
    Vediyappan G; Borisova T; Fralick JA
    J Bacteriol; 2006 Jun; 188(11):3757-62. PubMed ID: 16707668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal domain of AcrA is essential for the assembly and function of the multidrug efflux pump AcrAB-TolC.
    Ge Q; Yamada Y; Zgurskaya H
    J Bacteriol; 2009 Jul; 191(13):4365-71. PubMed ID: 19411330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes.
    Ghisalberti D; Masi M; Pagès JM; Chevalier J
    Biochem Biophys Res Commun; 2005 Mar; 328(4):1113-8. PubMed ID: 15707992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of the cryptic EefABC efflux pump in Enterobacter aerogenes chloramphenicol-resistant mutants.
    Masi M; Pagès JM; Pradel E
    J Antimicrob Chemother; 2006 Jun; 57(6):1223-6. PubMed ID: 16606635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
    Zhou X; Jia F; Liu X; Wang Y
    Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel macrolide-specific ABC-type efflux transporter in Escherichia coli.
    Kobayashi N; Nishino K; Yamaguchi A
    J Bacteriol; 2001 Oct; 183(19):5639-44. PubMed ID: 11544226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the role of TolC in multidrug efflux: the function and assembly of AcrAB-TolC tolerate significant depletion of intracellular TolC protein.
    Krishnamoorthy G; Tikhonova EB; Dhamdhere G; Zgurskaya HI
    Mol Microbiol; 2013 Mar; 87(5):982-97. PubMed ID: 23331412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay.
    Bohnert JA; Schuster S; Kern WV; Karcz T; Olejarz A; Kaczor A; Handzlik J; Kieć-Kononowicz K
    Antimicrob Agents Chemother; 2016 Apr; 60(4):1974-83. PubMed ID: 26824939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003.
    Chevalier J; Mulfinger C; Garnotel E; Nicolas P; Davin-Régli A; Pagès JM
    PLoS One; 2008 Sep; 3(9):e3203. PubMed ID: 18787654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.